I guess it would make analysis far easier if we knew what the Company's Business Plan is longer-term. Does it just wish to optimize short-term ( 5 years? ) returns by optimizing its appeal as a takeover target with current IP or does it want to be a long-term pharmaceutical technology development company seeking further uses of current IP and seeking out other projects? Maybe a good question for AGM?
Have they detailed their vision of recent times?
Share Price, page-2560
-
- There are more pages in this discussion • 8,872 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.48 |
Change
0.160(1.04%) |
Mkt cap ! $1.978B | |||
| Open | High | Low | Value | Volume |
| $15.10 | $15.48 | $15.04 | $6.154M | 402.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1498 | $15.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.50 | 8296 | 2 |
View Market Depth
| Last trade - 16.10pm 21/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |